Saturday, August 16, 2014

Argyria, side effect of Nanosilver

Nanosilver an experimental drug sent by a Nigerian scientist in the diaspora has arrived the country and will be used to treat victims of the Ebola virus. Nanosilver however doesn't come without its side effects which has been identified as Argyria

Argyria is a condition caused by inappropriate exposure to chemical compounds of the element silver. (James William D; et al, 2006:858). The most dramatic symptom of argyria is that the skin turns blue or bluish-grey.

Argyria is generally believed to be irreversible, with the only practical method of minimising its cosmetic disfigurement being to avoid the sun, but laser therapy has been used to treat it with satisfactory cosmetic results. It is not life-threatening but is cosmetically undesirable. (Lansdown,2006).
In the words of US-Based Critical Care Pharmacologist & Pharmaceutical Research Scientist, Professor Edward Oparaoji.
"Although Nanosilver is relatively safe, with its most common side effect being Argyria - a condition that turns the skin blue or bluish-grey, and worth trying in Ebola patients... Nevertheless, the Scientist who sent the medication should be commended."

"Half bread" they say "is better than none".

References
James, William D.; Berger, Timothy G.; Elston, Dirk M.; Odom, Richard B. (2006). Andrews' diseases of the skin: clinical dermatology. Saunders Elsevier. p. 858.

Lansdown AB (2006). "Silver in health care: antimicrobial effects and safety in use". Current Problems in Dermatology. Current Problems in Dermatology 33: 17–34.

http://www.atsdr.cdc.gov/tfacts146.html

1 comment: